CURRICULUM VITAE

                                                     Eric N. Miller, Ph.D., ABAP

http://www.calcaprt.com/emiller.htm                                                                      UCLA Psychology Clinic

Phone/Fax (310) 825-9689                                                                                                                             2191 Franz Hall

emiller@ucla.edu                                                                                                                        Los Angeles, CA  90095

                                                                                                                                                                                                               

 

EDUCATIONAL BACKGROUND

B.A. in Psychology (with High Distinction), University of Virginia, Charlottesville, 1977

M.S. in Clinical Psychology, University of Wisconsin, Madison, 1981

Ph.D. in Clinical Psychology, University of Wisconsin, Madison, 1986

Post-Doctoral Fellowship in Neuropsychology, University of California, Los Angeles, Neuropsychiatric Institute, 1986-88

 

LICENSURE/DIPLOMATE

Licensed Clinical Psychologist, State of California (PSY 10771), 1988

Diplomate, American Board of Assessment Psychology, 1996

 

CURRENT PROFESSIONAL, CLINICAL & RESEARCH POSITIONS

Research Neuropsychologist, UCLA Semel Institute for Neuroscience & Human Behavior, Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles. Asst Research 1988-1994; Assoc Research 1994-2000; Research 2000-present).

Clinical Professor of Psychology, Coordinator of Assessment Services, Clinical Supervisor, UCLA Department of Psychology, University of California, Los Angeles, 1996-present.

Director and Co-Investigator, Neuropsychological Manifestations Study, NIAID Multicenter AIDS Cohort Study, UCLA School of Public Health, Division of Epidemiology, University of California, Los Angeles, 1987-present.

Co-Principal Investigator and Co-Director of Post-Doctoral Training, Neuropsychology of HIV Training Grant (NIMH), UCLA Department of Psychiatry and Biobehavioral Sciences, Neuropsychology, University of California, Los Angeles, 1990-present.

Owner, Norland Software, Computer Consulting and Software Development, Los Angeles, California, 1983-present.

 

PAST PROFESSIONAL, CLINICAL & RESEARCH EXPERIENCE

Clinical Professor of Psychiatry, UCLA Semel Institute for Neuroscience & Human Behavior, UCLA Resnick Neuropsychiatric Hospital, Department of Psychiatry and Biobehavioral Sciences, Geffen School of Medicine at UCLA, University of California, Los Angeles. Assistant Clinical Prof 1988-1994; Assoc Clin Prof 1994-2000; Clin Prof 2000-2011.

Co-Principal Investigator, Neurologic AIDS Research Center. UCLA Center for Health Sciences, AIDS Clinical Trial Group, UCLA CARE Center, University of California, Los Angeles, 2002-2008.

Director and Principal Investigator, Neurologic AIDS Research Center. UCLA Center for Health Sciences, AIDS Clinical Trial Group, UCLA CARE Center, University of California, Los Angeles, 1993-2002.

Supporting Faculty, Interdisciplinary Training in HIV/AIDS Epidemiology. UCLA School of Public Health, University of California, Los Angeles, 1994-2006.

Neuropsychological Consultant and Co-Investigator, Health Costs and Services Utilization Mental Health Study (HCSUS Mental Health).  UCLA/Drew University/RAND, Los Angeles, 1994-1998.

Neuropsychological Consultant, Women and Family Project, UCLA Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, 1995-2000.

Neuropsychological Consultant, NIDA/NIMH Study on Neurobehavioral Factors in Black Men at Risk for AIDS, Harbor-UCLA Medical Center, Charles R. Drew Medical Center, Los Angeles, California, 1991-1994.

Clinical Neuropsychological Consultant, Kaiser Permanente, Long Beach, California, 1992-1994.

Neuropsychological Consultant, Prevalence of Dementia in a Cohort of HIV-infected Persons in Ruili, China, University of California, Berkeley, 1992-1993.

Advisor, World Health Organization Global Programme on AIDS.  Advisor on development of tools for cross-cultural assessment of cognitive functioning. World Health Organization, Geneva, Switzerland, 1990-1991.

Co-Investigator, American Foundation for AIDS Research study using EEG and computerized neuropsychological procedures for early detection of HIV dementia. University of California, Los Angeles, California, 1988-1989.

 

SOCIETIES AND HONORS

American Psychological Association, Section 9, Division 12; International Neuropsychological Society; Fellow, American Academy of Assessment Psychology (1997-present); Ittleson Consulting Fellow-Group for the Advancement of Psychiatry Committee on Aging (1992-94); Wisconsin Alumni Research Fund Fellow (1977-79); Honors with High Distinction in Psychology–University of Virginia (1977); Phi Beta Kappa; Echols Scholar–University of Virginia (1973-77)

 

RESEARCH AND SCIENTIFIC REVIEW BOARDS

Ad-Hoc reviewer: Archives of General Psychiatry, Cognitive and Behavioral Neurology, Journal of Abnormal Psychology, Journal of Acquired Immune Deficiency Syndromes, Journal of Clinical and Experimental Neuropsychology, Journal of the International Neuropsychological Society, Journal of Neuropsychiatry and Clinical Neurosciences, Journal of Neuro-AIDS, Neurology, Neuropsychology, Psychological Assessment, Scandinavian Journal of Psychology. Ad-hoc reviewer for VA Medical Research Service, National Institute of Neurological Disorders and Stroke, UCLA AIDS Institute, the Wellcome Trust (UK).

 

 

 

PROFESSIONAL SERVICE

APA Committee on Psychological Tests and Assessment (2006-2008); Advisor, World Health Organization Global Programme on AIDS (1990-92); Editorial board, Journal of Neuro-Behavioral HIV Medicine (2009-present); Consulting Editor, Psychological Assessment (1992-96); Chair, Multicenter AIDS Cohort Study Neuropsychology Working Group (1998-2011); AIDS Clinical Trials Group Neurology Core Committee (1995-2007); UCLA Post-Doctoral Trainee Selection Committee (1994-present)

 

CLINICAL TRIALS

1.      Principal Investigator for UCLA Site.  Randomized, Double Blind, Placebo Controlled Trial of Nimodipine for the Neurological Manifestations of HIV-1 (ACTG 162).  NIAID, Miles Pharmaceuticals, Burroughs Wellcome Company, 9/93-2/94.

2.      Neuropsychological Consultant. A Phase I/II Clinical and Pharmacokinetic Trial of Pentoxifylline in Patients with HIV-Associated Neurologic Dysfunction Receiving Concomitant Antiretroviral Therapy.  Hoechst-Roussel Pharmaceuticals, Inc. 1994-1995.

3.      Principal Investigator for UCLA Site. A Phase II/III Double Blind Trial of Amitriptyline and Mexiletine for Painful Neuropathy in HIV Infections (ACTG 242).  NIAID, Boehringer Ingelheim Pharmaceuticals, 1994-1999.

4.      Principal Investigator for UCLA Site; Neuropsychological Consultant. A Randomized, Placebo Controlled, Double-Blind, Dose-Finding Study of Peptide T on Neurocognitive Function in HIV Cognitive/Motor Complex (PT-US-002).  Peptech USA, Peptech Europe, 9/95-2/96.

5.      Principal Investigator for UCLA Site; Study Neuropsychologist. Randomized, double-blinded, placebo-controlled trial of memantine for AIDS Dementia Complex (ADC) as concurrent therapy with best current antiretroviral therapy (ACTG 301). NIAID; NIMH; Neurobiological Technologies Inc, 1996-2007.

6.      Principal Investigator for UCLA Site. Nerve Growth Factor for Painful Neuropathy in HIV (ACTG 291). NIAID; Genentech, 1996-2000.

7.      Co-investigator for UCLA Site. Randomized, Double-Blind, Parallel Group, Placebo Controlled, Tolerability, Safety and Pilot Efficacy Study of CPI-1189 in HIV Infected Individuals with Cognitive and Motor Impairment (NARC 003). NINDS; Centaur Pharmaceuticals, 1999-2000.

8.      Protocol Neuropsychologist and co-PI for UCLA Site. Phase II, Placebo-controlled, Double-blind Study of The Selegiline Transdermal System (STS) in the Treatment of HIV Associated Cognitive Impairment (ACTG A5090). NIAID, 1999-2007.

 

RESEARCH AWARDS

1.      Principal Investigator.  Computerized Assessment of Cognitive Decline in the Aged.  USPHS, 1 F32 AG05431-01.  (NIH, 09/87-08/89). 

2.      Project Director and Co-Investigator.  The Natural History of Acquired Immune Deficiency Syndrome (AIDS) in Homosexual Men (NIAID, U01-AI-35040, 9/87-3/14).  PI = Roger Detels, M.D.

3.      Co-Investigator.  Early Detection of HIV Dementia.  (AmFAR, 6/88-5/89).  PI = Andrew Leuchter, M.D. 

4.      Principal Investigator and Director. UCLA ACTG Neurologic Center. (NINDS 1 P01 NS32228-01, 12/93-11/02); Co-PI and Co-Director, 12/03-9/05.  

5.      Co-Investigator. HIV Cost and Services Utilization Study (HCSUS). (AHCPR/NIMH U01-HS08578, 9/94 - 8/98).

6.      Principal Investigator. Peptide T for Treatment of HIV Dementia (Peptech PT-US-002, 5/95 - 9/96).

7.      Co-Principal Investigator. Neuropsychology AIDS Fellowship (NIMH T32 MH 19535, 9/96 - 6/11).

8.      Co-Investigator. 1H-MRS Studies in HIV Dementia (NIMH R01-NS36524, 4/97-11/06). PI = Bradford Navia, M.D.

9.      Co-Investigator. HIV and Aging: Impact on Cognition and Mortality (NIMH R03-MH086131, 10/08-9/10). PI = Karl Goodkin, M.D., Ph.D.

10.  Co-Investigator. The Impact of Host Genetics and Stimulant Use on Neurocognition in HIV+ Adults. (NIDA R03-DA026099, 10/08-9/10). PI = Andrew Levine, Ph.D.

11.  Co-Investigator. Multicenter AIDS Cohort Study ARRA Supplement – Neuroimaging. (NIAID U01-AI35041, 6/10 – 5/11). PI = Charles Rinaldo, Ph.D.

12.  Co-Investigator. Pathways to HIV-associated neurocognitive disorders: a systems biology approach. (NIDA R01-DA030913, 9/10 – 7/15). PI = Andrew Levine, Ph.D.

13.  Co-Investigator. Cardiovascular and HIV/AIDS effects on brain structure/function and cognition. (NIA R01-AG034852, 9/10 – 8/15). PI = James Becker, Ph.D.

 

PUBLICATIONS

ORIGINAL ARTICLES AND INVESTIGATIONS:

1.      Chapman LJ, Chapman JP, Miller EN. Reliabilities and intercorrelations of eight measures of proneness to psychosis. Journal of Consulting and Clinical Psychology. 1982;50:187-195.

2.      Miller EN, Chapman LJ. Continued word association in hypothetically psychosis-prone college students. Journal of Abnormal Psychology. 1983;92:468-478.

3.      Muehlenhard CL, Miller EN. Traditional and nontraditional men's responses to women's dating initiation. Behavior Modification. 1988;12:385-403.

4.      Resnick HS, Foy DW, Donahoe CP, Miller EN. Antisocial behavior and posttraumatic stress disorder in Vietnam veterans. Journal of Clinical Psychology. 1989;45:860-866.

5.      Van Gorp WG, Miller EN, Satz P, Visscher B. Neuropsychological performance in HIV-1 immunocompromised patients: a preliminary report. Journal of Clinical and Experimental Neuropsychology. 1989;11:763-773.

6.      Van Gorp WG, Satz P, Hinkin C, Evans G, Miller EN. The neuropsychological aspects of HIV-1 spectrum disease. Psychiatric Medicine. 1989;7:59-78.

7.      Miller EN, Selnes OA, McArthur JC, Satz P, Becker JT, Cohen BA, Sheridan K, Machado AM, Van Gorp WG, Visscher B. Neuropsychological performance in HIV-1 infected homosexual men: the Multicenter AIDS Cohort Study (MACS). Neurology. 1990;40:197-203.

8.      Selnes OA, Miller E, McArthur J, Gordon B, Muņoz A, Sheridan K, Fox R, Saah AJ, the Multicenter AIDS Cohort Study. HIV-1 infection: no evidence of cognitive decline during the asymptomatic stages. Neurology. 1990;40:204-208.

9.      American Academy of Neurology AIDS Task Force. Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Report of a working group of the American Academy of Neurology AIDS Task Force. Neurology. 1991;41:778-785.

10.  Miller EN, Satz P, Visscher BV. Computerized and conventional neuropsychological assessment of HIV-1 infected homosexual men. Neurology. 1991;41:1608-1616.

11.  Satz P, Miller EN, Selnes OA, Van Gorp W, D'Elia LF, Visscher B. Hand preference in homosexual men. Cortex. 1991;27:295-306.

12.  Selnes OA, Jacobson L, Machado AM, Becker JT, Wesch J, Miller EN, Visscher B, McArthur J, the Multicenter AIDS Cohort Study. Normative data for a brief neuropsychological screening battery. Perceptual and Motor Skills. 1991;73:539-550.

13.  van Gorp WG, Satz P, Hinkin C, Selnes O, Miller EN, McArthur J, Cohen B, Paz D, the Multicenter AIDS Cohort Study. Metacognition in HIV-1 seropositive asymptomatic individuals: Self-ratings versus objective neuropsychological performance. Journal of Clinical and Experimental Neuropsychology. 1991;13:812-819.

14.  McArthur JC, Nance-Sproson TE, Griffin DE, Hoover D, Selnes OA, Miller EN, Margolick JB, Cohen BA, Farzadegan H, Saah A, the Multicenter AIDS Cohort Study. The diagnostic utility of elevation in cerebrospinal fluid b2 microglobulin in HIV-1 dementia. Neurology. 1992;42:1707-1712.

15.  Nuwer MR, Miller EN, Visscher BR, Niedermeyer E, Packwood JW, Carlson LG, Satz P, Jankel W, McArthur JC. Asymptomatic HIV infection does not cause EEG abnormalities: results from the Multicenter AIDS Cohort Study (MACS). Neurology. 1992;42:1214-1219.

16.  Riedel RR, Helmstaedter C, Bülau P, Durwen HF, Brackmann H, Fimmers R, Clarenbach P, Miller EN, Böttcher M. Early signs of cognitive deficits among human immunodeficiency virus-positive hemophiliacs. Acta Psychiatrica Scandinavica. 1992;85:321-326.

17.  Hugdahl K, Satz P, Mitrushina M, Miller EN. Left-handedness and old age: do left-handers die earlier? Neuropsychologia. 1993;31:325-333.

18.  McArthur JC, Hoover DR, Bacellar H, Miller EN, Cohen BA, Becker JT, Graham NMH, McArthur JH, Selnes OA, Jacobson LP, Visscher BR, Concha M, Saah A. Dementia in AIDS patients: incidence and risk factors. Neurology. 1993;43:2245-2252.

19.  Satz P, Morgenstern H, Miller EN, Selnes OA, McArthur JC, Cohen BA, Becker JT, Wesch J, Jacobson L, D'Elia LF, Van Gorp W, Visscher B. Low education as a possible risk factor for cognitive abnormalities in HIV-1: findings from the Multicenter AIDS Cohort Study (MACS). Journal of Acquired Immune Deficiency Syndromes. 1993;6:503-511.

20.  van Gorp WG, Hinkin C, Satz P, Miller EN, Weisman J, Holston S, Drebing C, Marcotte TD, Dixon W. Subtypes of HIV-related neuropsychological functioning: a cluster analysis approach. Neuropsychology. 1993;7:62-72.

21.  Drebing CE, Van Gorp WG, Hinkin C, Miller EN, Satz P, Kim DS, Holston S, D'Elia LF. Confounding factors in the measurement of depression in HIV. Journal of Personality Assessment. 1994;62:68-83.

22.  van Gorp WG, Miller EN, Marcotte TD, Dixon W, Paz D, Selnes O, Wesch J, Becker JT, Hinkin CH, Mitrushina M, Satz P, Weisman JD, Buckingham SL, Stenquist PK. The relationship between age and cognitive impairment in HIV-1 infection: findings from the Multicenter AIDS Cohort Study and a clinical cohort.  Neurology. 1994;44:929-935.

23.  Newton TF, Leuchter AF, Miller EN, Weiner H. Quantitative EEG in patients with AIDS and asymptomatic HIV infection. Clinical Electroencephalography. 1994;25:18-25.

24.  Newton TF, Leuchter AF, Walter DO, Van Gorp WG, Morgenstern H, Miller EN, Lieb K, Visscher B, Satz P, Weiner H. Electroencephalographic coherence in AIDS. Psychiatry Research. 1994;54:1-11.

25.  Uchiyama CL, D'Elia LF, Dellinger AM, Becker JT, Selnes OA, Wesch JE, Chen BB, Satz P, van Gorp W, Miller EN, the Multicenter AIDS Cohort Study. Longitudinal comparison of alternate versions of the Symbol Digit Modalities Test: issues of form comparability and moderating demographic variables. The Clinical Neuropsychologist. 1994;8:209-218.

26.  Bacellar H, Muņoz A, Miller EN, Cohen BA, Besley D, Selnes OA, Becker JT, McArthur JC. Temporal trends in the incidence of HIV-1 related neurologic diseases: Multicenter AIDS Cohort Study, 1985-1992. Neurology.  1994;44:1892-1900.

27.  Miller EN, Fujioka TAT, Chapman LJ, Chapman JP. Psychometrically matched tasks for assessment of hemispheric asymmetries of function. Brain and Cognition. 1995;28:1-13.

28.  Uchiyama CL, D'Elia LF, Dellinger AM, Becker JT, Selnes OA, Wesch JE, Chen BB, Satz P, van Gorp W, Miller EN, the Multicenter AIDS Cohort Study . Alternate forms of the auditory-verbal learning test: issues of test comparability, longitudinal reliability, and moderating demographic variables. Archives of Clinical Neuropsychology. 1995;10:133-145.

29.  Selnes OA, Galai N, Bacellar H, Miller EN, Becker JT, Wesch J, van Gorp W, McArthur JC. Cognitive performance after progression to AIDS: a longitudinal study from the Multicenter AIDS Cohort Study.  Neurology. 1995;46:267-275.

30.  van Gorp WG, Hinkin CH, Moore LH, Miller EN, Marcotte TD, Satz P, Weisman J. Ascertainment bias and neuropsychological performance in HIV-1 disease.  Neuropsychology. 1995;9:206-210.

31.  Miller EN, Fujioka TAT, Chapman LJ, Chapman JP. Hemispheric asymmetries of function in patients with major affective disorders. Journal of Psychiatric Research. 1995;29:173-183.

32.  Schwartzman WA, Patnaik M, Angulo FJ, Visscher BR, Miller EN, Peter JB. Bartonella (Rochalimaea) antibodies, dementia, and cat ownership among men infected with human immunodeficiency virus.  Clinical Infectious Diseases. 1995;21:954-959.

33.  Hugdahl K, Zaucha K, Satz P, Mitrushina M, Miller E. Left-handedness and age: comparing writing/drawing and other manual activities. Laterality. 1996; 1: 177-183.

34.  Sacktor NC, Bacellar H, Hoover DR, Nance-Sproson TE, Selnes OA, Miller EN, Dal Pan GJ, Kleeberger C, Brown A, Saah A, McArthur JC. Psychomotor slowing in HIV infection: a predictor of dementia, AIDS, and death. Journal of Neurovirology. 1996; 2: 404-410.

35.  Llorente AM, Miller EN, D’Elia LF, Selnes OA, Wesch J, Becker JT, Satz P for the Multicenter AIDS Cohort Study (MACS). Slowed information processing in HIV-1 disease. Journal of Clinical and Experimental Neuropsychology. 1998; 20: 60-72.

36.  Dal Pan GJ, Farzadegan H, Selnes OA, Hoover DR, Miller EN, Skolasky RL, Nance-Sproson TE, McArthur JC. Sustained cognitive decline in HIV infection: relation to CD4+ cell count, plasma viremia, and p24 antigenemia. Journal of Neurovirology. 1998; 4: 95-99.

37.  Navia BA, Dafni U, Simpson D, Tucker T, Singer E, McArthur JC, Yiannoutsos C, Zaborski L, Lipton SA, for the AIDS Clinical Trials Group (site Principal Investigator). A phase I/II trial of nimodipine for HIV-related neurologic complications. Neurology, 1998; 51: 221-228.

38.  Kieburtz K, Simpson D, Yiannoutsos C, Max MB, Hall CD, Ellis RJ, Marra CM, McKendall R, Singer E, Dal Pan GJ, Clifford DB, Tucker T, Cohen B, and the AIDS Clinical Trial Group 242 Protocol Team (site Principal Investigator). A randomized trial of amitriptyline and mexiletine for painful neuropathy in HIV infection. Neurology, 1998; 51: 1682-1688.

39.  Childs EA, Lyles RH, Selnes OA, Chen B, Miller EN, Cohen BA, Becker JT, Mellors J, McArthur JC. Plasma viral load and CD4 lymphocytes as predictive markers for HIV-associated dementia and sensory neuropathy. Neurology. 1999; 52: 607-613.

40.  Sacktor NC, Lyles RH, Skolasky RL, Anderson DE, McArthur JC, McFarlane G, Selnes OA, Becker JT, Cohen B, Wesch J, Miller EN. Combination antiretroviral therapy improves psychomotor speed performance in HIV+ homosexual men. Neurology. 1999; 52: 1640-1647.

41.  Chang L, Ernst T, Leonido-Yee M, Witt M, Speck O, Walot I, Miller EN. Highly active antiretroviral therapy reverses cerebral metabolite abnormalities in mild HIV-dementia. Neurology,  1999; 53: 782-789.

42.  Richardson MA, Satz P, Myers HF, Miller EN, Bing EG, Fawzy FI, Maj M. Effects of depressed mood versus clinical depression on neuropsychological test performance among African American men impacted by HIV/AIDS. Journal of Clinical and Experimental Neuropsychology, 1999; 6: 769-783.

43.  Durvasula RS, Myers HF, Satz P, Miller EN, Morgenstern H, Richardson MA, Evans G, Forney D. HIV-1, cocaine, and neuropsychological performance in African American men. Journal of the International Neuropsychological Society, 2000; 6: 322-335.

44.  Speck O, Ernst T, Braun A, Koch C, Miller EN, Chang L. Gender differences in the functional organization of the brain for working memory. NeuroReport, 2000; 11: 2581-2585.

45.  McArthur JC, Yiannoutsos C, Simpson DM, Adornato BT, Singer EJ, Hollander H, Marra C, Rubin M, Cohen BA, Tucker T, Navia BA, Schifitto G, Katzenstein D, Rask C, Zaborski L, Smith ME, Shriver S, Millar L, Clifford DB, and the AIDS Clinical Trials Group Team 291 (site Principal Investigator). A phase II trial of nerve growth factor for sensory neuropathy associated with HIV infection. Neurology, 2000; 54: 1080-1088.

46.  Durvasula RS, Miller EN, Myers HF, Wyatt GE. Predictors of neuropsychological performance in HIV positive women. Journal of Clinical and Experimental Neuropsychology, 2001; 23: 149-163.

47.  Sacktor N, Lyles R, Skolasky R, Kleeberger C, Selnes OA, Miller EN, Becker JT, Cohen B, McArthur JC, and the Multicenter AIDS Cohort Study. HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990-1998. Neurology, 2001; 56: 257-260.

48.  Volkow ND, Chang L, Wang G-J, Fowler JS, Leonido-Yee M, Francesci D, Sedler MJ, Gatley SJ, Hitzemann R, Ding Y-S, Logan J, Wong C, Miller EN. Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. American Journal of Psychiatry, 2001; 158: 377-382.

49.  Sacktor N, Tarwater PM, Skolasky RL, McArthur JC, Selnes OA, Becker J, Cohen B, Miller EN for the Multicenter AIDS Cohort Study (MACS). CSF antiretroviral drug penetrance and the treatment of HIV-associated psychomotor slowing. Neurology, 2001; 57: 542-544.

50.  Chang L, Speck O, Miller EN, Braun J, Jovicich J, Koch C, Itti L, Ernst T. Neural correlates of attention and working memory deficits in HIV patients. Neurology, 2001; 57: 1001-1007.

51.  Schifitto G, Yiannoutsos C, Simpson DM, Adornato BT, Singer EJ, Hollander H, Marra CM, Rubin M, Cohen BA, Tucker T, Koralnik IJ, Katzenstein D, Haidich B, Smith ME, Shriver S, Millar L, Clifford DB, McArthur JC, and the AIDS Clinical Trials Group Team 291 (site Principal Investigator). Long-term treatment with recombinant nerve growth factor for HIV-associated sensory neuropathy. Neurology, 2001; 57: 1313-1316.

52.  Volkow ND, Chang L, Wang GJ, Fowler JS, Franceschi D, Sedler M, Gatley SJ, Miller E, Hitzemann R, Ding YS, Logan J. Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. The Journal of Neuroscience, 2001; 21: 9414-9418.

53.  Chang L, Ernst T, Speck O, Petal H, DeSilva M, Leonido-Yee M, Miller EN. Perfusion MRI and computerized cognitive tests abnormalities in abstinent methamphetamine users. Psychiatry Research, 2002; 114: 65-79.

54.  Polk S, Muņoz A, Sacktor NC, Jenkins F, Cohen B, Miller EN, Jacobson LP. A case-control study of HIV-1-related dementia and co-infection with HHV-8. Neurology, 2002; 59: 950-953.

55.  Chang L, Ernst T, Witt MD, Ames N, Gaiefsky M, Miller E. Relationships among brain metabolites, cognitive function, and viral loads in antiretroviral-naive HIV patients. NeuroImage, 2002; 17: 1638-1648.

56.  Chang L, Ernst T, Witt MD, Ames N, Walot I, Jovicich J, DeSilva M, Trivedi N, Speck O, Miller EN. Persistent brain abnormalities in antiretroviral-naive HIV patients 3 months after HAART. Antiviral Therapy, 2003; 8: 17-26.

57.  Farinpour R, Miller EN, Satz P, Selnes OA, Cohen BA, Becker JT, Skolasky RL, Visscher BR. Psychosocial risk factors of HIV morbidity and mortality: findings from the Multicenter AIDS Cohort Study. Journal of Clinical and Experimental Neuropsychology, 2003; 25: 654-670.

58.  Sacktor N, Skolasky RL, Tarwater PM, McArthur JC, Selnes OA, Becker J, Cohen B, Visscher B, Miller EN for the Multicenter AIDS Cohort Study (MACS). Response to systemic HIV viral load suppression correlates with psychomotor speed performance. Neurology, 2003; 61: 567-569.

59.  Wang G-J, Volkow ND, Chang L, Miller E, Sedler M, Hitzemann R, Zhu W, Logan J, Ma Y, Fowler JS. Partial recovery of brain metabolism in methamphetamine abusers after protracted abstinence. American Journal of Psychiatry, 2004; 161: 242-248.

60.  Yiannoutsos CT, Ernst T, Chang L, Lee PL, Richards T, Marra CM, Meyerhoff DJ, Jarvik JG, Kolson D, Schifitto G, Ellis RJ, Swindells S, Simpson DM, Miller EN, Gonzalez RG, Navia BA. Regional patterns of brain metabolites in AIDS Dementia Complex. NeuroImage, 2004; 23: 928-935.

61.  Chang L, Lee PL, Yiannoutsos CT, Ernst T, Marra CM, Richards T, Kolson D, Schiffito G, Jarvik JG, Miller EN, Lenkinski R, Gonzalez G, Navia BA for the HIV MRS Consortium. A multicenter in vivo proton-MRS study of HIV-associated dementia and its relationship to age.  NeuroImage, 2004; 23: 1336-1347.

62.  Levine AJ, Miller EN, Becker JT, Selnes OA, Cohen BA and the Multicenter AIDS Cohort Study. Normative data for determining significance of test-retest differences on eight common neuropsychological instruments. The Clinical Neuropsychologist, 2004; 18(3) 373-384.

63.  Chang L, Cloak C, Patterson K, Grob C, Miller EN, Ernst T. Enlarged striatum in abstinent methamphetamine abusers: a possible compensatory response. Biological Psychiatry, 2005; 57: 967-974.

64.  Levine AJ, Hardy DJ, Miller E, Castellon SA, Longshore D, Hinkin CH. The effect of recent stimulant use on sustained attention in HIV-infected adults. Journal of Clinical and Experimental Neuropsychology, 2006; 28: 29-42.

65.  Paul R, Yiannoutsos CT, Miller EN, Singer E, Lee PL, Chang L, Marra CM, Schifitto G, Ernst T, Richards T, Jarvik J, Price R, Myerhoff DJ, Kolson D, Ellis RJ, Gonzalez G, Lenkinski R, Cohen RA, Navia BA for the ACTG 301 and 700 teams and the HIV MRS Consortium. Proton MRS and neurocognitive correlates in AIDS Dementia Complex: evidence of subcortical specificity. Journal of Neuropsychiatry and Clinical Neurosciences, 2007; 19: 283-292.

66.  Levine AJ, Hinkin CH, Miller EN, Becker JT, Selnes OA, Cohen BA for the Multicenter AIDS Cohort Study. The generalizability of neurocognitive test/retest data derived from a nonclinical sample for detecting change among two HIV+ cohorts. Journal of Clinical and Experimental Neuropsychology, 2007; 29: 669-678. PMCID: PMC2863993

67.  Schifitto G, Navia BA, Yiannoutsos CT, Marra CM, Chang L, Ernst T, Miller EN, Singer E, Simpson D, Shriver S, Gonzalez RG, Lipton SA, and the Adult AIDS Clinical Trial Group (ACTG) 301 and 700 Teams and the HIV MRS Consortium. Memantine and HIV-associated cognitive impairment: a neuropsychological and proton magnetic resonance spectroscopy study. AIDS, 2007; 21: 1877-1886.

68.  Schifitto G, Zhang J, Evans SR, Sacktor N, Simpson D, Millar LL, Hung VL, Miller EN, Smith E, Ellis RJ, Valcour V, Singer E, Marra CM, Kolson D, Weihe J, Remmel R, Katzenstein D, Clifford DB, and the ACTG A5090 Team. A multicenter trial of Selegiline Transdermal System for HIV-associated cognitive impairment. Neurology, 2007; 69: 1314-1321.

69.  Cole MA, Margolick JB, Cox C, Li X, Selnes OA, Martin EM, Becker JT, Aronow HA, Cohen B, Sacktor N, Miller EN. Longitudinally preserved psychomotor speed in long-term asymptomatic HIV-infected individuals. Neurology, 2007; 69: 2213-2220.

70.  Evans SR, Yeh T, Sacktor N, Clifford DB, Simpson D, Miller EN, Ellis RJ, Valcour V, Marra CM, Millar L, Schifitto G, for the AIDS Clinical Trials Group and the Neurologic AIDS Research Consortium. Selegiline Transdermal System (STS) for HIV-Associated Cognitive Impairment: Open-Label Report of ACTG 5090. HIV Clinical Trials, 2007; 8: 437-446.

71.  Chang L, Wong V, Nakama H, Watters M, Ramones D, Miller EN, Cloak C, Ernst T. Greater than age-related changes in brain diffusion of HIV patients after one year. Journal of Neuroimmune Pharmacology, 2008; 3: 265-274.  PMCID: PMC2693362

72.  Wright MJ, Woo E, Schmitter-Edgecombe M, Hinkin CH, Miller EN, Gooding AL. The Item Specific Deficit Approach (ISDA) to evaluating verbal memory dysfunction: Rationale, psychometrics and application. Journal of Clinical and Experimental Neuropsychology, 2009; 31: 790-802. PMCID: PMC2879263

73.  Becker JT, Kingsley L, Mullen J, Cohen B, Martin E, Miller EN, Ragin A, Sacktor N, Selnes OA, Visscher BR. Vascular risk factors and human immunodeficiency virus serostatus convey different risks for cognitive dysfunction in gay/bisexual men. Neurology, 2009; 73: 1292-1299. PMCID: PMC2764414

74.  Zhao Y, Navia BA, Marra CM, Singer EJ, Chang L, Berger J, Ellis RJ, Kolson DL, Simpson D, Miller EN, Lipton SA, Evans SR, Schifitto G, and the Adult AIDS Clinical Trial Group (ACTG) 301 team. Memantine for AIDS Dementia Complex: Open-label report of ACTG 301. HIV Clinical Trials,2010; 11: 59-67. PMCID: PMC2981797

75.  Becker JT, Sanders J, Madsen SK, Ragin A, Kingsley L, Maruca V, Cohen B, Goodkin K, Martin E, Miller EN, Sacktor N, Alger JR, Barker PB, Saharan P, Carmichael OT, Thompson PM for the Multicenter AIDS Cohort Study. Subcortical brain atrophy persists even in HAART-regulated HIV disease. Brain Imaging and Behavior, 2011; 5: 77-85. PMCID: PMC3082694

76.  Sacktor N, Skolasky RL, Cox C, Selnes O, Becker JT, Cohen B, Martin-Thormeyer E, Miller EN for the Multicenter AIDS Cohort Study (MACS). Longitudinal psychomotor speed performance in HIV+ individuals: impact of age and serostatus. Journal of NeuroVirology, 2010; 16:335-341. PMCID: PMC3068912

77.  Wright MJ, Woo E, Foley J, Ettenhofer ML, Cottingham ME, Gooding AL, Jang J, Kim MS, Castellon SA, Miller EN, Hinkin CH. Antiretroviral adherence and the nature of HIV-associated verbal memory impairment. Journal of Neuropsychiatry and Clinical Neurosciences, 2011; 23: 324-331.

78.  Becker JT, Maruca V, Kingsley L, Sanders J, Alger JR, Barker P, Goodkin K, Martin E, Miller E, Ragin A, Sacktor N, Selnes O for the Multicenter AIDS Cohort Study. Factors affecting brain structure in gay/bisexual men with HIV disease in the post-HAART era. Neuroradiology, 2011; March 22 [Epub ahead of print]. PMCID: PMC3154580

79.  Chang L, Andres M, Sadino J, Jiang CS, Nakama H, Miller E, Ernst T. Impact of Apolipoprotein E epsilon 4 and HIV on cognition and brain atrophy: antagonistic pleiotropy and premature brain aging. NeuroImage, 2011; 58: 1017-1027.

80.  Goodkin K, Fernandez F, Forstein M, Miller EN, Becker JT, Douaihy A, Cubano L, Santos FH, Filho NS, Zirulnik J, Singh D. A perspective on the proposal for neurocognitive disorder criteria in DSM-5 as applied to HIV-associated neurocognitive disorders. Neuropsychiatry, 2011; 1: 431-440.

81.  Ragin AB, D’Souza G, Reynolds S, Miller E, Sacktor N, Selnes OA, Martin E, Visscher BR, Becker JT. Platelet decline as a predictor of brain injury in HIV infection. Journal of NeuroVirology, 2011; 17: 487-495.

82.  Wright MJ, Miller EN, Reinhard MJ, Cottingham ME, Cox C, Reynolds S, Martin EM, Becker JT, Selnes OA, Manly J. The role of education level and quality in neuropsychological test performances of ethnic minorities. Submitted to Journal of Clinical and Experimental Neuropsychology.

83.  Vo Q, Cox C, Li X, Jacobson L, McKaig R, Sacktor N, Miller EN. Changes in performance on neuropsychological tests before and after HIV-1 seroconversion: the Multicenter AIDS Cohort Study (MACS). Submitted to AIDS.

84.  Mateen FJ, Shinohara RT, Carone M, Miller EN, McArthur JC, Jacobson LP, Sacktor N. Incidence of neurological disorders in men over 40 years old: Multicenter AIDS Cohort Study. Submitted to Neurology.

85.  Levine AJ, Service S, Miller EN, Reynolds SM, Singer EJ, Shapshak P, Martin EM, Sacktor N, Becker JT, Jacobson LP, Freimer N. Genomewide association study of neurocognitive impairment and dementia in HIV-infected adults. Submitted to American Journal of Experimental Genetics.

86.  Hines LJ, Miller EN, Hinkin CH, Alger JR, Barker P, Goodkin K, Martin EM, Maruca V, Ragin A, Sacktor N, Sanders J, Selnes O, Becker JT for the Multicenter AIDS Cohort Study. Cortical brain atrophy and intra-individual variability in neuropsychological test performance in HIV disease. Submitted to Brain Imaging and Behavior.

 

NEUROPSYCHOLOGICAL TESTS AND EDUCATIONAL MATERIALS:

1.      Miller EN. Survey of Attitudes and Experiences among Gay Men (SAE-GM). Madison, Wisconsin: University of Wisconsin; 1980.

2.      Cook M, Fischer J, Miller E. Psychology: Test Item File. Englewood Cliffs, NJ: Prentice-Hall, Inc.; 1982.

3.      Miller EN. Norsoft Hangman. Educational software for vocabulary development (6th grade to adult, 9th grade to adult) and cognitive rehabilitation. Madison, Wisconsin: Norland Software, 1983.

4.      Miller EN. Foreign Language Hangman. Educational software for teaching Introductory Spanish and French (3rd grade to adult). Madison, Wisconsin: Norland Software, 1983.

5.      Miller EN. Continued Word Association Test. Madison, Wisconsin: University of Wisconsin; 1983.

6.      Miller EN, Fujioka TAT. Similarities/Line Orientation Task. Madison, Wisconsin: University of Wisconsin; 1985.

7.      Miller EN, Fujioka TAT. Word-Finding/Dot Localization Task. Madison, Wisconsin: University of Wisconsin; 1985.

8.      Miller EN. California Computerized Assessment Package. Los Angeles: Norland Software; 1990.

9.      Miller EN. Decision Maze Interactive Learning System. Customizable system for developing interactive teaching materials. Los Angeles: Norland Software, 1992.  A special version for use in training principles of geropsychiatry was modeled for the American Psychiatric Press.

10.  Miller EN. California Computerized Assessment Package (CalCAP). 2nd Edition. Los Angeles: Norland Software; 1999.

 

CHAPTERS:

1.      Van Gorp WG, Hinkin C, Satz P, Miller EN, D'Elia LF. Neuropsychological findings in HIV infection, encephalopathy and dementia. In: Parks RW, Zec RF, Wilson RS, eds. Neuropsychology of Alzheimer's Disease and Other Dementias. New York: Oxford Press; 1993: 153-185.

2.      Miller EN, Wilkie FL. Computerized testing to assess cognition in HIV-positive individuals. In: Grant I, Martin A, eds. Neuropsychology of HIV Infection: Current Research and New Directions. New York: Oxford; 1994: 161-175.

3.      Selnes OA, Miller EN. Development of a screening battery for HIV-related cognitive impairment: the MACS experience. In: Grant I, Martin A, eds. Neuropsychology of HIV Infection: Current Research and New Directions. New York: Oxford University Press; 1994: 176-187.

4.      Flaskerud JH, Miller EN. Psychosocial and neuropsychiatric dysfunction. In: Ungvarski PJ, Flaskerud JH, eds. HIV/AIDS: A Guide to Primary Care Management. 4th edition. Philadelphia: WB Saunders Company; 1998: 255-291.

5.      Reinhard MJ, Satz P, Selnes OA, Sacktor N, Cohen BA, Becker JT, & Miller EN. Brain Reserve: HIV Morbidity and Mortality. In: Stern, Y, ed. Cognitive Reserve. London, UK: Psychology Press, Taylor & Francis Ltd.; 2006: 207-218.

 

LETTERS TO THE EDITOR:

1.      Nuwer MR, Miller EN, Visscher BR, Satz P. Early neurologic abnormalities in HIV infection [letter]. New England Journal of Medicine. 1991;324:492-493.

2.      Miller EN, Satz P, Visscher B. Neuropsychological tests in HIV: reply from the authors [letter]. Neurology. 1992;42:2056.

3.      Selnes OA, Miller EN. Cognitive impairment in HIV infection [letter]. AIDS. 1992;6:602-604.

4.      Miller EN, Satz P, Bing EG, Van Gorp W, Morgenstern H, Visscher B. Methodological issues in the assessment of Human Immunodeficiency Virus-related cognitive impairment [commentary]. Archives of General Psychiatry. 1992;49:586-587.

5.      Nuwer MR, Miller EN, Visscher BR, Packwood JW, Carlson LG, Satz P, Niedermeyer E, Jankel W, McArthur JC. EEG findings in asymptomatic HIV: reply from the authors. Neurology. 1993;43:635-636.

6.      Selnes OA, Miller EN. Asymptomatic HIV-1 infection and aviation safety [consensus statement]. Aviation,Space,and Environmental Medicine. 1993;64:172-173.

7.      Miller EN, Selnes OA. Aviation safety and asymptomatic HIV-1 infection [letter]. Aviation, Space, and Environmental Medicine. 1993;64:1059-1060.

8.      Miller EN, Satz P, Selnes OA. Problems with causal inference in cross-sectional studies of HIV infection [commentary]. Journal of Neuropsychiatry and Clinical Neurosciences.  1994;6:201-202.

9.      Miller EN, Selnes OA, Satz P. Methods of controlling for demographic differences in neuropsychological studies of HIV infection [commentary]. AIDS. 1994;8:280-281.

 

PEER-REVIEWED ABSTRACTS AND PRESENTATIONS:

1.      Muehlenhard CL, Miller EN. Traditional and nontraditional men's responses to women's dating initiation. Annual Meeting of the Association for the Advancement of Behavior Therapy. 1983.

2.      Muehlenhard CL, Scardino TJ, Miller EN. Consequences of women's dating initiation: Two studies. Conference on Research in Family Therapy. 1985.

3.      Miller EN. Hemispheric asymmetries of function in patients with major affective disorders. Dissertation Abstracts International. 1987;47:5061B.

4.      Miller EN, Satz P, Van Gorp W, Visscher B, Dudley J. Computerized screening for HIV-related cognitive decline in gay men. International Conference on AIDS. 1988;3(1):378.

5.      Resnick HS, Foy DW, Miller EN, Donahoe CP. Antisocial behavior and posttraumatic stress disorder in Vietnam veterans. Annual Meeting of the American Psychological Association. 1988.

6.      Satz P, Miller EN, Visscher B, Van Gorp W, D'Elia LF, Dudley J. Changes in mood as a function of HIV serostatus: A 3-year longitudinal study. International Conference on AIDS. 1988;3(2):408.

7.      Selnes O, Miller EN, Becker JT, Cohen BA, McArthur JC, Visscher B, Gordon B, Satz P, Ginzburg HM. Normal neuropsychological performance in healthy HIV-1 infected homosexual men: The Multicenter AIDS Cohort Study (MACS). International Conference on AIDS. 1988;3(2):399.

8.      Leuchter AF, Newton T, Van Gorp W, Miller EN. Early detection of HIV effects on brain function. Annual Meeting of the American Psychiatric Association. 1989.

9.      McArthur JC, Miller EN, Selnes OA, Becker J, Cohen BA, Starkey D, Saah A, Fox R. Effects of azidothymidine on neuropsychological performance in asymptomatic and symptomatic HIV-1 infection. International Conference on AIDS. 1989;5:452.

10.  Miller EN, Selnes OA, Cohen B, Becker J, Park L, Satz P, McArthur JC, Sheridan K, Visscher B. Cognitive abnormalities as a function of HIV-1 clinical status and use of azidothymidine (AZT): The Multicenter AIDS Cohort Study (MACS). International Conference on AIDS. 1989;5:462.

11.  Miller EN, Selnes OA, Visscher B, McArthur JC, Satz P, Dudley J. Changes in performance on the Trail-Making test before and after HIV-1 seroconversion and diagnosis of AIDS: The Multicenter AIDS Cohort Study (MACS). International Conference on AIDS. 1989;5:464.

12.  Miller EN, Satz P, Van Gorp W, Visscher B, Dudley J. Computerized screening for HIV-related cognitive decline in gay men: Cross-sectional analyses and one-year follow-up. International Conference on AIDS. 1989;5:465.

13.  Miller EN, Satz P, Visscher B. Computerized neuropsychological assessment for HIV-related encephalopathy. Journal of Clinical and Experimental Neuropsychology. 1989;11:34-35.

14.  Selnes OA, McArthur JC, Miller EN, Sheridan K, Becker JT, Gordon B, the Multicenter AIDS Cohort Study. Further evidence of lack of HIV-1 related cognitive impairment during the asymptomatic stages: The Multicenter AIDS Cohort Study (MACS). International Conference on AIDS. 1989;5:210.

15.  Selnes OA, Miller EN, McArthur JC, Cohen B, Becker JT, Saah A, et al . Neuropsychological follow-up in patients who have progressed to AIDS: The Multicenter AIDS Cohort Study (MACS). International Conference on AIDS. 1989;5:449.

16.  Selnes OA, Muņoz A, Miller E, Cohen B, Sheridan K. HIV-1 infection: No evidence of cognitive decline during the asymptomatic stage. Neurology. 1989;39(suppl):426.

17.  Selnes OA, McArthur JC, Miller E, Sheridan K, Gordon B, Polk BF. Longitudinal neuropsychological assessment of healthy HIV-1 carriers: No evidence of significant cognitive decline. Journal of Clinical and Experimental Neuropsychology. 1989;11:78.

18.  Van Gorp W, Miller EN, Satz P, Visscher B. Neuropsychological performance in HIV-1 immunocompromised patients. International Conference on AIDS. 1989;5:464.

19.  Van Gorp WG, Miller EN, Satz P, Visscher B. Neuropsychological performance in HIV-1 immunocompromised patients. Journal of Clinical and Experimental Neuropsychology. 1989;11:35.

20.  Visscher B, Miller EN, Satz P, McArthur J, Selnes O, Cohen B, Becker J, English P, Nance-Sprosson L. Neuropsychological follow-up of 1787 participants in the Multicenter AIDS Cohort Study. International Conference on AIDS. 1989;5:449.

21.  Gallway RA, Millington JT, Mirsky AF, Van Gorp WG, Miller EN, Wolcott CL. Neuropsychological consequences of hyperbaric nitrogen narcosis. Annual Meeting of the National Academy of Neuropsychology. 1990.

22.  McArthur JC, Miller EN, Selnes OA, Becker JT, Cohen BA, Starkey D, Hoover D, Saah A. Effects of long-term zidovudine use on neuropsychological performance in the Multicenter AIDS Cohort Study. International Conference on AIDS. 1990;6(2):97.

23.  McArthur JC, Miller EN, McArthur JH, Margolick J, Cohen BA, Griffin DE, Nance-Sproson T, Saah A, the Multicenter AIDS Cohort Study. CSF Beta-2 microglobulin levels in HIV-1 infection: Correlation with duration of infection and CD4 cell count. Neurology. 1990;40(suppl):237.

24.  Miller EN, Satz P, Van Gorp WG, Visscher B. Neuropsychological manifestations of HIV-1 infection: Cross-sectional and longitudinal perspectives. Symposium on HIV: Neurobehavioral correlates. Journal of Clinical and Experimental Neuropsychology. 1990;12:48.

25.  Selnes OA, McArthur JC, Miller EN, Cohen B, Wesch J, Becker J, McArthur JH, Saah A, Jacobson LP. Recent and remote syphilis and its relationship to neuropsychological test performance. International Conference on AIDS. 1990;6(2):169.

26.  Selnes OA, McArthur JH, Fox R, Starkey D, Miller EN, McArthur JC. Frontal lobe functioning in asymptomatic HIV-infection. Neurology. 1990;40(suppl):426.

27.  Bing EG, Miller EN, Muņoz A, Morgenstern H, Selnes OA, Cohen BA, Becker JT, Satz P. The effect of demographic factors on neuropsychological test performance in men at risk for HIV infection: the Multicenter AIDS Cohort Study. International Conference on AIDS. 1991;7(2):79.

28.  Gallway RA, Millington JT, Van Gorp WG, Miller EN, Mirsky AF. Neuropsychological consequences of hyperbaric nitrogen narcosis II. Journal of Clinical and Experimental Neuropsychology. 1991;13:440.

29.  Selnes OA, McArthur JC, Gordon B, Miller EN, McArthur JH, Saah A. Patterns of cognitive decline in incident HIV-dementia: Longitudinal observations from the Multicenter AIDS Cohort Study [Presentation]. Neurology. 1991;41 (Suppl 1):252.

30.  Visscher B, Morgenstern H, Miller EN, Satz P, Jin S, Jacobson L, Selnes O, Becker J, Cohen B, the Multicenter AIDS Cohort Study. Relationship of HIV serostatus and education with neuropsychological impairment in asymptomatic men. International Conference on AIDS. 1991;7(1):209.

31.  Bacellar H, McArthur JC, Hoover DR, Miller EN, Selnes OA, Cohen BA, Becker JT, Jacobson L, Saah A. Incidence, prevalence and risk of HIV dementia in homosexual men. Annual Meeting of the American Public Health Assocation. 1992.

32.  Drebing C, Van Gorp W, Hinkin C, Miller E, Satz P, Kim D. MMPI item analysis and the nature of the depression in HIV. Journal of Clinical and Experimental Neuropsychology. 1992;14:78-79.

33.  Hinkin CH, Van Gorp WG, Satz P, Miller E, Drebing C, Weisman J, Holston SG. Subject ascertainment bias and neuropsychological performance in HIV disease. Journal of Clinical and Experimental Neuropsychology. 1992;14:79.

34.  McArthur JC, Hoover DR, Bacellar H, Miller EN, Selnes OA, Cohen BA, Becker JT, Jacobson L, Saah A. Risk factors for development of HIV dementia in homosexual men: report from the Multicenter AIDS Cohort Study. International Conference on AIDS. 1992;8(2):220.

35.  Miller EN. Use of computerized reaction time in the assessment of dementia. Neurology. 1992;42:220.

36.  Pontón MO, Herrera L, Satz P, Miller EN, D'Elia LF. Neuropsychological impairment among HIV infected Spanish-speaking subjects. The Clinical Neuropsychologist. 1992; 6: 332.

37.  Pontón MO, Herrera L, Satz P, Young R, Miller EN, D'Elia LF. Neuropsychological impairment among HIV infected Spanish-speaking subjects. Presented at the 100th Annual Meeting of the American Psychological Association, Washington, DC. 1992.

38.  Van Gorp WG, Hinkin CH, Satz P, Miller E, Drebing C, Weisman J, Holston S, Marcotte T, Dixon W. Subtypes of HIV-associated neuropsychological performance: a cluster-analytic approach. Journal of Clinical and Experimental Neuropsychology. 1992;14:101.

39.  Hugdahl K, Satz P, Mitrushina M, Miller E. Incidence of left-handedness in young and old individuals. Journal of Clinical and Experimental Neuropsychology. 1993;15:26.

40.  Miller EN, Bing EG, Selnes OA, Wesch J, Becker JT. The effects of sociodemographic factors on reaction time and speed of information processing. Journal of Clinical and Experimental Neuropsychology. 1993;15:66.

41.  Miller EN, Selnes OA, Visscher BR. Cognition in asymptomatic HIV-1 infection: four-year longitudinal follow-up of AIDS-free subjects in the Multicenter AIDS Cohort Study (MACS). International Conference on AIDS. 1993;9(1):425.

42.  Selnes OA, Galai N, McArthur JC, Miller EN, Bacellar H, Cohen B, Wesch JE, Becker JT, Palenicek JG. Cognitive changes with progression to AIDS: a longitudinal study from the Multicenter AIDS Cohort Study (MACS). International Conference on AIDS. 1993;9(1):61.

43.  Miller EN, Visscher BR, Bing EG, McArthur JC, Cohen BA, Anderson R. Co-occurrence of HIV-associated cognitive/motor complex and other AIDS-defining illnesses. First National Conference on Human Retroviruses and Related Infections. 1993;1:143.

44.  Bacellar H, McArthur JC, Muņoz A, Cohen BA, Miller EN, Becker JT. Temporal trends in incidence of neurological diseases in AIDS. First National Conference on Human Retroviruses and Related Infections. 1993;1:181.

45.  Martin E, Miller EN. Contributions of cognitive neuropsychology to the study of dementia (symposium). Annual Meeting of the International Neuropsychological Society. Cincinnati, Ohio. February 1994, pp. 108-109.

46.  Bacellar H, Muņoz A, Miller EN, Cohen BA, Besley D, Selnes OA, Becker JT, McArthur JC. Temporal trends in the incidence of HIV-1 related neurologic diseases: Multicenter AIDS Cohort Study, 1985-1992. Pathogenesis of HIV infection of the Brain: Impact on Function and Behavior. National Institute of Mental Health. April 1994, p. 16.

47.  Miller EN. Pattern and prevalence of HIV-1-associated cognitive impairment: results from the MACS. Neuropsychopharmacology. 1994;10:643S.

48.  van Gorp W, Marcotte T, Satz P, Miller E, Selnes O, Wesch J, Becker J, Jacobson L, Morgenstern H, Visscher B. Evidence for cognitive reserve in HIV infection: Additional findings from the Multicenter AIDS Cohort Study (MACS). Journal of the International Neuropsychological Society. 1995;1:379.

49.  Miller EN. Cognitive testing using reaction time and traditional neuropsychological procedures. Journal of the International Neuropsychological Society. 1995;1:393.

50.  Stern MJ, Miller EN, McArthur JC, Chen BB, Galai N, Becker JT, Cohen BA. Immune markers of neuropsychological status: a report from the Multicenter AIDS Cohort Study. Neurology. 1995;45:A443.

51.  Durvasula RS, Satz P, Hinkin CH, Uchiyama C, Morgenstern H, Miller EN, Jin S, Sorenson D, Van Gorp W, Visscher BR, Mitchell M. Does practice make perfect? Results of a six year longitudinal study with semi-annual testings. Archives of Clinical Neuropsychology. 1996; 11: 386.

52.  Cohen BA, Chmiel J, McArthur JC, Chu C, Miller EN, Selnes O, Becker JT, Wesch J, Phair JP. Factors affecting survival after diagnosis of AIDS dementia in the Multicenter AIDS Cohort Study (MACS). Presented at the American Academy of Neurology, 1996.

53.  Sacktor NC, Bacellar H, Hoover DR, Selnes OA, Miller EN, Brown A, DalPan GJ, Nance-Sproson TE, McArthur JC. Psychomotor slowing in HIV infection predicts onset of dementia. Presented at the American Academy of Neurology, 1996.

54.  Nance-Sproson TE, Dal Pan GJ, Hoover DR, Miller EN, McArthur JC. Projecting risks and morbidity from HIV-associated sensory neuropathy in the Multicenter AIDS Cohort Study (MACS).  Presented at the Neuroscience of HIV Infection, Paris, 1996.

55.  Sacktor NC, Bacellar H, Hoover DR, Selnes OA, Miller EN, Brown A, Dal Pan GJ, Nance-Sproson TE, McArthur JC. Psychomotor slowing in HIV infection predicts increased risk of dementia, AIDS, and death. Presented at the Neuroscience of HIV Infection, Paris, 1996.

56.  Durvasula RS, Miller EN, Wyatt GE. Neuropsychological performance in HIV positive women. Symposium presentation. Women and HIV Conference, Pasadena, California, May 5, 1997.

57.  Durvasula RS, Miller EN, Myers HM, Satz P, Wyatt G. Neuropsychological performance and HIV-1 in ethnic minority samples of women and men: serostatus effects, comparative data and methodological considerations. Journal of the International Neuropsychological Society, 4(1): 77, 1998.

58.  Durvasula RS, Miller EN, Wyatt GE. Longitudinal assessment of neuropsychological performance in HIV+ women (baseline and 6 months). Presented at the 12th World AIDS Conference, Geneva, Switzerland, International Conference on AIDS, 12:470, 1998.

59.  Sacktor NC, Skolasky R, Lyles R, McFarlane G, Anderson DE, Miller EN, Selnes OA, McArthur JC. Highly active antiretroviral therapy (HAART) improves cognitive impairment in HIV+ homosexual men. Presented at the Neuroscience of HIV Infection, Chicago, Journal of Neurovirology, 4(suppl): 365, 1998.

60.  Childs E, Lyles RH, Miller EN, Cohen BA, Chen BB, Mellors J, McArthur JC. Predictive markers for HIV-associated dementia and sensory neuropathy. Presented at the 12th World AIDS Conference, Geneva, Switzerland, 1998.

61.  Lee L, Ernst T, Yiannoutsos C, Miller EN, Chang L, Lenkenski R, Gonzalez RG, Navia B and the HIV MRS Research Consortium. A multicenter proton magnetic resonance spectroscopy (1HMRS) study of HIV brain injury. Presented at the Neuroscience of HIV Infection, Chicago, 1998.

62.  Chang L, Ernst T, Leonido-Yee M, Walot I, Miller EN, Singer E. Cerebral metabolite abnormalities correlate with clinical severity of HIV-1 cognitive motor complex. Presented at the Neuroscience of HIV Infection, Chicago. Journal of Neurovirology, 4(suppl): 345, 1998.

63.  Chang L, Ernst T, Leonido-Yee M, Witt M, Speck O, Miller E. Reversal of cerebral metabolite abnormalities with highly active antiretroviral therapy (HAART) in HIV-1 dementia. Presented at the 7th Annual UCLA AIDS Institute Scientific Symposium, Los Angeles, 1998.

64.  Chang L, Speck O, Miller E, Braun A, Itti L, Ernst T. Increased usage of brain reserve capacity in patients with early stages of HIV-Cognitive Motor Complex. Presented at the 7th Annual UCLA AIDS Institute Scientific Symposium, Los Angeles, 1998.

65.  Durvasula RS, Miller EN, Wyatt G. Neuropsychological performance in HIV+ women: baseline data. Journal of the International Neuropsychological Society, 5(2): 97, 1999.

66.  Farinpour R, Miller EN, Castellon S. Depressive symptoms as predictors of HIV morbidity and mortality. Presented at the National Academy of Neuropsychology, Washington, DC, 1999.

67.  Farinpour R, Miller EN, Satz P. Cognitive and psychosocial risk factors of HIV morbidity and mortality. Journal of the International Neuropsychological Society, 5(2): 154, 1999.

68.  Sacktor N, Skolasky R, Lyles R, McFarlane G, Anderson D, Miller EN, Selnes O, Becker J, Wesch J, McArthur J. HIV-associated psychomotor slowing improves with combination antiretroviral therapy. Presented at the American Neuropsychiatric Association Meeting, 1999.

69.  Sacktor NC, Lyles RH, McFarlane G, Skolasky RL, Kleeberger C, Becker JT, Cohen B, Wesch J, Miller EN, McArthur JC. The changing incidence of HIV-1-related neurological diseases: 1990-1997. Presented at the 6th Conference on Retroviruses and Opportunistic Infections, Chicago, 1999.

70.  Navia BA, Lee PL, Chang L, Ernst T, Miller E, Kolson D, Marra C, Jarvik J, Todd R, Schifitto G, Swindells S, McConnell J, Yiannoutsos C, Lenkinski R, Gonzalez G and the HIV MRS Consortium.  Metabolite changes in the basal ganglia provide a signature for the AIDS Dementia Complex: a multicenter proton magnetic resonance study. Presented at the annual meeting of the American Academy of Neurology, Toronto. Neurology, 52: 254, 1999.

71.  Yiannoutsos C, Miller E, Chang L, Ernst T, Kolson D, Marra C, Jarvik J, Richards T, Schifitto G, Swindells S, McConnell J, Lee PL, Gonzalez G, Rajicic N, Lenkinski R,  Navia BA, and the HIV MRS Consortium. Proton MRS and neuropsychological assessments in AIDS Dementia Complex: a measure of subcortical function. Presented at the annual meeting of the American Academy of Neurology, Toronto. Neurology, 52: 253-254, 1999.

72.  Sacktor N, Lyles RH, McFarlane G, Skolasky RL, Kleeberger C, Becker JT, Cohen B, Wesch J, Miller EN, McArthur JC, and the Multicenter AIDS Cohort Study. HIV-1-related neurological disease incidence changes in the era of highly active antiretroviral therapy. Presented at the annual meeting of the American Academy of Neurology, Toronto. Neurology, 52: 252-253, 1999.

73.  Chang L, Speck O, Miller E, Leonido-Yee M, Patel H, Ernst T. Cerebral perfusion abnormalities and gender effects in abstinent methamphetamine users. Presented at the annual College on Problems of Drug Dependence meeting, Acapulco, 1999.

74.  Chang L, Speck O, Miller E, Braun J, Itti L, Ernst T. Increased usage of brain reserve capacity in patients with HIV. Presented at the annual meeting of the International Society for Magnetic Resonance in Medicine, Philadelphia, 1999.

75.  Speck O, Chang L, Braun J, Miller E, Ernst T. Gender differences in lateralization of activated brain areas during a working memory task measured with fMRI. Presented at the annual meeting of the International Society for Magnetic Resonance in Medicine, Philadelphia, 1999.

76.  McArthur JC, Enger C, Jacobson L, Gore ME, Miller EN, Cohen BA, Becker JT, Kleeberger C, Kaslow R. Influence of human major histocompatibility complex genes on the development of HIV-associated dementia. Presented at the American Neurological Association, 1999.

77.  Lam MN, Hinkin CH, Satz P, Becker JT, Selnes OA, Sacktor NC, Cohen BA, Wesch J, Durvasula RS, Ishikawa S, Castellon SA, Farinpour R, Hardy DJ, Miller EN for the Multicenter AIDS Cohort Study (MACS). Practice effects and neuropsychological test performance: longitudinal analysis of demographic and disease associated prognostic indicators. Presented at the annual meeting of the International Neuropsychological Society, Denver. Journal of the International Neuropsychological Society, 6: 165, 2000.

78.  Polk S, Jacobson LP, Sacktor N, Jenkins F, Cohen B, Miller E, Muņoz A, for the Multicenter AIDS Cohort Study (MACS). Investigation of the proposed protective effect of HHV-8 against HIV-1-related dementia. Presented at the 7th Conference on Retroviruses and Opportunistic Infections, San Francisco, 2000.

79.  Chang L, Ernst T, Witt M, DeSilva M, Jovicich J, Walot I, Ames N, Trivedi N, Miller E. Cerebral metabolite abnormalities in antiretroviral-naive HIV patients before and after HAART. Presented at the American Academy of Neurology, San Diego, 2000.

80.  Yiannoutsos CT, Lee PL, Chang L, Ernst T, Miller E, Kolson D, Lenkinski R, Marra C, Jarvic J, Richards T, Schifitto G, Swindells S, McConnell J, Gonzalez G, Navia BA, for the proton MRS consortium. Patterns of regional brain metabolism in AIDS Dementia Complex. Presented at the American Academy of Neurology, San Diego, 2000.

81.  Miller EN, Yiannoutsos CT, Lee PL, Chang L, Ernst T, Marra CM, Jarvic J, Kolson D, Schifitto G, Lenkinski R, Gonzalez RG, Navia BA and the HIV MRS Consortium. Brain metabolism and neuropsychological function in AIDS Dementia Complex (ADC). Presented at the Neuroscience of HIV Infection 2000, Edinburgh, 2000.

82.  Yiannoutsos CT, Lee PL, Chang L, Ernst T, Miller EN, Kolson D, Lenkinski R, Marra CM, Jarvik J,  Richards T, Schifitto G, Swindells S, McConnell J, Gonzalez RG, Navia BA.  Patterns of regional brain metabolism in AIDS Dementia Complex.  Neuroscience of HIV Infection Edinburgh, UK, June 22-24, 2000.

83.  Sacktor NC, Skolasky RL, Becker J, Cohen B, Miller EN, McArthur JC. Cerebrospinal fluid (CSF) antiretroviral drug penetrance and treatment of HIV-associated cognitive impairment. Presented at the Neuroscience of HIV Infection 2000, Edinburgh, 2000.

84.  Navia BA, Yiannoutsos CT, Change L, Marra CM, Miller E, Nath A, Berger J, Kolson D, Schifitto G, Ellis R, Simpson D, Swindells S, Price R, Rajicic N. ACTG 301: A phase II randomized, double-blind, placebo-controlled trial of memantine for AIDS Dementia Complex (ADC).  Neurology, 56 (8): A474-A475 Suppl. 3 Apr 24 2001.

85.  Sacktor NC, Skolasky RL, Tarwater PM, McArthur JC, Selnes OA, Becker J, Cohen B, Miller EN.  The relationship between viral load response to highly active antiretroviral therapy and psychomotor speed performance in HIV+ homosexual men. Presented at the Neuroscience of HIV Infection 2002, Dusseldorf, 2002.

86.  Cloak CC, Chang L, Miller E, Ernst T. Increased subcortical diffusion is associated with poorer cognitive scores in HIV. Presented at the International Society for Magnetic Resonance in Medicine (ISMRM), Toronto, 2003.

87.  Cloak C, Chang L, Patterson K, Grob C, Miller E, Ernst T. Sex-Differences in neuropsychological function and brain morphometry in methamphetamine users.Oral Presentation at 65th Annual Meeting of College on Problems of Drug Dependence (CPDD), Bal Harbour, Florida, June 2003.

88.  Cloak CC, Chang L, Conant K, Ernst T, Zimmerman L, Miller EN. Increased CSF monocyte chemotactic protein-1 correlates with psychomotor slowing in HIV patients. Presented at 33rd Annual Society for Neuroscience meeting, New Orleans, November 2003.

89.  Cloak CC, Chang L, Miller EN, Ernst T. Poorer cognitive scores in HIV are associated with increased white matter diffusion. Presented at HIV Molecular and Clinical Neuroscience Workshop, Baltimore, September 2003.

90.  Leckova K, Chang L, Cloak C, Warren K, Miller E. Marijuana exacerbates psychomotor slowing in HIV. Presented at the 10th Annual Society on NeuroImmune Pharmacology, Santa Fe, New Mexico, March 2004.

91.  Levine A, Miller E, Becker J, Selnes O, Cohen B for the Multicenter AIDS Cohort Study. Regression equations derived from non-clinical samples are useful in detecting cognitive decline among a demographically similar HIV-infected cohort. Archives of Clinical Neuropsychology, 19(7), 944. Presented at the annual meeting of the National Academy of Neuropsychology, Seattle, Washington, November 2004.

92.  Hardy DJ, Borghi SW, Lodato JE, Zolnikof B, Miller EN, Green MF, Parasuraman R, Hinkin CH. HIV, aging, and cognitive task demands. Presented at the annual meeting of the National Academy of Neuropsychology, Seattle, Washington, November 2004.

93.  Schifitto G, Sacktor N, Zhang J, Evans S, Simpson D, Millar L, Miller E, Smith E, Goodhead M, Clifford D and the ACTG A5090 Team. A phase-II, placebo-controlled, double-blind placebo controlled study of the selegiline transdermal system in the treatment of HIV-associated cognitive impairment. Presented at the 13th Conference on Retroviruses and Opportunistic Infections, Denver, Colorado, February 2006.

94.  Cole M, Margolick JB, Cox C, Li X, Selnes OA, Martin EM, Becker JT, Aronow HA, Miller EN. (2007). Longitudinal study of cognitive functioning in long-term asymptomatic HIV-infected individuals. Journal of the International Neuropsychological Society, 13 (S1), 220-221. Presented at the International Neuropsychological Society, Portland, Oregon, February 2007.

95.  Cole M, Margolick JB, Cox C, Li X, Selnes OA, Martin EM, Becker JT, Aronow HA, Miller EN. Longitudinal study of psychomotor speed and cognitive flexibility in long-term immunologically asymptomatic HIV-infected individuals. Paper presented at the 14th Conference on Opportunistic Infections and Retroviruses, Los Angeles, CA, February 2007.

96.  Wright MJ, Woo E, Schmitter-Edgecombe M, Hinkin CH, Miller EN. The Item Specific Deficit approach to evaluating verbal memory dysfunction: rationale, psychometrics and application. Paper presented at the 37th Annual Meeting of the International Neuropsychological Society, Atlanta, GA, February 2008.

97.  Becker JT, Kingsley L, Mullen J, Cohen B, Martin E, Miller E, Ragin A, Sacktor N, Selnes OA, Visscher BR. Vascular risk factors and human immunodeficiency virus convey different risks for cognitive dysfunction in gay/bisexual men. Presented at the 61st Annual Meeting of the American Academy of Neurology, Seattle, WA, April 2009.

98.  Sacktor N, Skolasky R, Selnes O, Becker J, Cohen B, Martin E, Visscher B, Miller E. Longitudinal changes in psychomotor speed test performance among HIV+ and HIV- individuals: the impact of age and serostatus. Presented at the 61st Annual Meeting of the American Academy of Neurology, Seattle, WA, April 2009.

99.        Wright MJ, Woo E, Foley J, Ettenhofer ML, Cottingham ME, Gooding AL, Jang J, Kim MS, Castellon SA, Miller EN, Hinkin CH. HAART adherence and the expression of verbal memory impairment in HIV. Presented at the American Neuropsychiatric Association (ANPA) Annual Meeting, Tampa, Florida, March 2010.

100.    Levine A, Service S, Miller E, Singer E, Freimer N. Genome wide association study of HIV-associated neurocognitive disorders: preliminary report. Presented at the 16th annual meeting of the Society of NeuroImmune Pharmacology, Manhattan Beach, California, April 2010.

101.    Becker JT, Cohen B, Martin E, Miller E, Sanders J, Ragin A, Sacktor N, Selnes O, Carmichael O. Predictors of ventricular volume in HIV disease. Presented at American Academy of Neurology (AAN) Annual Meeting, Toronto, Ontario, April 2010.

102.    Mateen FJ, Shinohara RT, Carone M, Sacktor N, Miller EN, McArthur JC, Jacobson LP for the Multicenter AIDS Cohort Study. Incidence of stroke and all neurological disorders by age in HAART-treated human immunodeficiency virus-positive versus HIV-negative individuals. Presented at American Academy of Neurology (AAN) Annual Meeting, Honolulu, Hawaii, April 2011.

103.    Vo Q, Cox C, Li X, Jacobson L, McKaig R, Miller E. Changes in performance on neuropsychological tests before and after HIV-1 SC: 25 years of data from the Multicenter AIDS Cohort Study (MACS). Presented at the 19th Conference on Retroviruses and Opportunistic Infections, Seattle, Washington, March 2012.

104.    Becker J, Ragin A, Teverovisky L, Goodkin K, Kingsley L, Martin E, Miller E, Sacktor N, Selnes O, Shah N for the Multicenter AIDS Cohort Study. White matter lesions, gray matter atrophy and cognition in HIV disease. Presented at the 19th Conference on Retroviruses and Opportunistic Infections, Seattle, Washington, March 2012.

105.    Mateen FJ, Shinohara RT, Carone M, Sacktor N, Miller EN, McArthur JC, Jacobson LP for the Multicenter AIDS Cohort Study. Attributable Burden of Neurological Disease in Older HIV-Positive versus HIV-Negative Men: Findings from the Multicenter AIDS Cohort Study (MACS), 1997-2009. To be presented at American Academy of Neurology (AAN) Annual Meeting, New Orleans, Louisiana, April 2012.

 

                                   

Current as of October 6, 2011.